Literature DB >> 22134790

Laser treatment for retinopathy of prematurity.

Samuel K Houston1, Charles C Wykoff, Audina M Berrocal, Ditte J Hess, Timothy G Murray.   

Abstract

Retinal development involves a complex coordination of events that may be affected by premature delivery, leading to retinopathy of prematurity (ROP), a potential blinding childhood disease. The avascular retina drives further disease progression, with laser ablation reducing unfavorable anatomic outcomes as well as maintaining visual acuity. Trials have stressed the importance of early identification and treatment of threshold and high-risk prethreshold disease to improve outcomes. Retinal ablation with laser photocoagulation should involve entire treatment of avascular retina with a confluent laser spot density, avoiding skip lesions. The current review highlights the use of laser photocoagulation in the treatment of ROP.

Entities:  

Mesh:

Year:  2011        PMID: 22134790     DOI: 10.1007/s10103-011-1021-z

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  60 in total

1.  Direct observation of the effect of oxygen on developing vessels: preliminary report.

Authors:  N ASHTON; C COOK
Journal:  Br J Ophthalmol       Date:  1954-07       Impact factor: 4.638

2.  Screening examination of premature infants for retinopathy of prematurity.

Authors: 
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

3.  Fibroblastic Overgrowth of Persistent Tunica Vasculosa Lentis in Infants Born Prematurely: II. Report of Cases-Clinical Aspects.

Authors:  T L Terry
Journal:  Trans Am Ophthalmol Soc       Date:  1942

4.  Vascular morphogenesis in the retina of the cat.

Authors:  I C MICHAELSON
Journal:  J Anat       Date:  1948-07       Impact factor: 2.610

5.  Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.

Authors:  Wei-Chi Wu; Po-Ting Yeh; San-Ni Chen; Chung-May Yang; Chi-Chun Lai; Hsi-Kung Kuo
Journal:  Ophthalmology       Date:  2010-07-29       Impact factor: 12.079

Review 6.  Laser treatment for retinopathy of prematurity.

Authors:  J A McNamara
Journal:  Curr Opin Ophthalmol       Date:  1993-06       Impact factor: 3.761

7.  15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.

Authors:  Earl A Palmer; Robert J Hardy; Velma Dobson; Dale L Phelps; Graham E Quinn; C Gail Summers; Carol P Krom; Betty Tung
Journal:  Arch Ophthalmol       Date:  2005-03

8.  A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.

Authors:  Eugene Y J Ng; Brian P Connolly; J Arch McNamara; Carl D Regillo; James F Vander; William Tasman
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

9.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.

Authors:  William V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.

Authors:  S Kusaka; C Shima; K Wada; H Arahori; H Shimojyo; T Sato; T Fujikado
Journal:  Br J Ophthalmol       Date:  2008-07-11       Impact factor: 4.638

View more
  13 in total

1.  Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

Authors:  Julie Y C Lok; Wilson W K Yip; Abbie S W Luk; Joyce K Y Chin; Henry H W Lau; Alvin L Young
Journal:  Int Ophthalmol       Date:  2017-01-04       Impact factor: 2.031

2.  Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?

Authors:  Eşay Kıran Yenice; Caner Kara
Journal:  Int Ophthalmol       Date:  2022-09-23       Impact factor: 2.029

Review 3.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

4.  Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants.

Authors:  Yi Chen; Jing Feng; Clare Gilbert; Hong Yin; Jianhong Liang; Xiaoxin Li
Journal:  PLoS One       Date:  2015-02-09       Impact factor: 3.240

5.  Retinal laser services in Bhutan: a 3-year national survey.

Authors:  Bhim B Rai; Michael G Morley; Pema Zangmo; Thukten Tshering; Abi N Khatiwara; Paul S Bernstein; Ted Maddess
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

Review 6.  Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again.

Authors:  Mitsuru Arima; Yuya Fujii; Koh-Hei Sonoda
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

7.  7, 8-Dihydroxyflavone, a TrkB receptor agonist, provides minimal protection against retinal vascular damage during oxygen-induced ischemic retinopathy.

Authors:  Ismail S Zaitoun; Yong-Seok Song; Andrew Suscha; Mohamed El Ragaby; Christine M Sorenson; Nader Sheibani
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

8.  Morphology and Vessel Density of the Macula in Preterm Children Using Optical Coherence Tomography Angiography.

Authors:  Agnieszka Czeszyk; Wojciech Hautz; Maciej Jaworski; Dorota Bulsiewicz; Justyna Czech-Kowalska
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

Review 9.  Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.

Authors:  Chang Dai; Keith A Webster; Amit Bhatt; Hong Tian; Guanfang Su; Wei Li
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

Review 10.  Complications of retinopathy of prematurity treatment.

Authors:  Joshua M Barnett; G Baker Hubbard
Journal:  Curr Opin Ophthalmol       Date:  2021-09-01       Impact factor: 4.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.